Keros Therapeutics (KROS) Return on Sales [ROS] (2019 - 2026)
Keros Therapeutics' Return on Sales [ROS] came in at -351.69% for Q2 2026, down 132.53 percentage points from -219.16% a year earlier.
Powered by 
Analysis
Keros Therapeutics (KROS) Return on Sales [ROS] (2019 - 2026) Analysis & Trends
For FY2025, Keros Therapeutics' Return on Sales [ROS] was 27.69%, up 5966.64 percentage points from FY2024.
- Return on Sales [ROS] carries a four-year change of +308.15 percentage points (FY2021 to FY2025).
- Going back by year, Return on Sales [ROS] was -5938.96% in FY2024 (+106604.75 pp), -112543.71% in FY2023 and -280.46% in FY2021.
- The five-year range for quarterly Return on Sales [ROS] is -541000.00% (Q3 2023) to 71.97% (Q1 2025).
- Year-over-year, Return on Sales [ROS] increased in five of the last seven quarters, with an average year-over-year change of +108604.39 percentage points.
- The fastest year-over-year change in Return on Sales [ROS] over five years came in Q3 2024 (a gain of 525882.22 percentage points), and the weakest in Q3 2023 (a drop of 540769.22 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 28.37% |
| 10 | Keros Therapeutics | 222.95 Mn | -1.71 Bn | - | -351.69% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -351.69% |
| Dec 31, 2025 | -7,602.60% |
| Sep 30, 2025 | -107.87% |
| Jun 30, 2025 | -219.16% |
| Mar 31, 2025 | 71.97% |
| Dec 31, 2024 | -1,750.62% |
| Sep 30, 2024 | -15,117.78% |
| Jun 30, 2024 | -136,321.62% |
| Mar 31, 2024 | -58,413.25% |
| Dec 31, 2023 | -32,486.01% |
| Sep 30, 2023 | -541,000.00% |
| Dec 31, 2022 | -637.72% |
| Sep 30, 2022 | -230.78% |
| Jun 30, 2022 | -210.31% |
| Mar 31, 2022 | -134.03% |
| Dec 31, 2021 | -24.33% |
| Sep 30, 2021 | -64,798.00% |
| Jun 30, 2021 | -15,541.00% |
| Sep 30, 2020 | -1,443.76% |
| Jun 30, 2020 | -529.44% |
API Access
Keros Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();